10 ML etomidate 2 MG/ML Injection — RxCUI 1654006
RxNorm drug concept · Semantic clinical drug
RxCUI 1654006
Semantic clinical drug · SCD
● Current RxNorm concept 26 FDA products
27 package NDCs
Snapshot Jul 14, 2026
What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.
🗂️ Key Facts
RxCUI1654006
Official name10 ML etomidate 2 MG/ML Injection
Concept typeSemantic clinical drug (SCD)
RxNorm statusCurrent RxNorm concept
Also known asetomidate 20 MG per 10 ML Injection; etomidate 20 MG in 10 ML Injection
FDA products mapped26
Package NDCs mapped27
Reported Medicaid activity (SDUD)858 prescriptions · 7 state & territory Medicaid programs · latest period Q4 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026
📖 Skip the Codes — Read It in Plain English.
Our pharmacist-built guide to Etomidate: what it is, how it’s used, side effects, and interactions.
📗 Our plain-language guide HelloPharmacist
- Etomidate is a fast-acting anesthetic given through an IV to put you into a deep sleep before surgery or another procedure. One of its biggest advantages is that it has very little...
- What exactly is etomidate, and why did my doctor choose it for my procedure?
- Some people notice a brief burning or pain sensation in the vein where the IV is placed — this is common and usually mild. You may also experience some involuntary muscle twitching...
- Will I feel anything during the injection, and what should I expect right after?
🕸️ Concept Web — How 10 ML etomidate 2 MG/ML Injection Connects
One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept
10 ML etomidate 2 MG/ML Injection
RxCUI 1654006 Semantic clinical drug · SCD
Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.
-
Ingredients 1
The active substance itself — no strength, form, or brand attached yet.
-
Etomidate
4177IN
-
Etomidate
-
Brand names 1
The same medicine's trade names. A brand name alone says nothing about strength or form.
-
Amidate
215216BN
-
Amidate
-
Dose forms 6
The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.
-
Etomidate Injection
1653759SCDF -
Etomidate Injectable Product
1157926SCDG -
Etomidate Injection [Amidate]
1653769SBDF -
Amidate Injectable Product
1171391SBDG -
Injection
1649574DF -
Injectable Product
1151126DFG
-
Etomidate Injection
-
Clinical & branded drugs 3
Ingredient + strength + dose form. These are the concepts real FDA products actually carry.
-
Etomidate 2 MG/ML
315911SCDC -
10 ML etomidate 2 MG/ML Injection [Amidate]
1654009SBD -
Etomidate 2 MG/ML [Amidate]
567637SBDC
-
Etomidate 2 MG/ML
Showing up to 8 concepts per family — 11 of 11 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.
🔀 Generic ⇄ Brand Crosswalk
The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.
Generic (Clinical) Concepts
-
Etomidate 2 MG/ML
SCDC · 315911 -
Etomidate Injection
SCDF · 1653759 -
Etomidate Injectable Product
SCDG · 1157926
Brand-Name Concepts
-
10 ML etomidate 2 MG/ML Injection [Amidate]
SBD · 1654009 -
Etomidate 2 MG/ML [Amidate]
SBDC · 567637 -
Etomidate Injection [Amidate]
SBDF · 1653769 -
Amidate Injectable Product
SBDG · 1171391 -
Amidate
BN · 215216
📦 FDA Products & Package NDCs
26 products · 27 package NDCs
27 package NDCs map to RxCUI 1654006 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
| Package NDC | Package | Brand / generic name | Labeler | Marketing start |
|---|---|---|---|---|
| 00143-9310-10 | 10 VIAL, SINGLE-DOSE in 1 CARTON (0143-9310-10) / 10 mL in... | Etomidate | Hikma Pharmaceuticals USA Inc. | 2016-02-25 |
| 00143-9311-10 | 10 VIAL, SINGLE-DOSE in 1 CARTON (0143-9311-10) / 20 mL in... | Etomidate | Hikma Pharmaceuticals USA Inc. | 2016-02-25 |
| 00143-9506-10 | 10 VIAL, SINGLE-DOSE in 1 CARTON (0143-9506-10) / 10 mL in... | Etomidate | Hikma Pharmaceuticals USA Inc. | 2016-02-25 |
| 00143-9507-10 | 10 VIAL, SINGLE-DOSE in 1 CARTON (0143-9507-10) / 20 mL in... | Etomidate | Hikma Pharmaceuticals USA Inc. | 2016-02-25 |
| 00404-9811-10 | 1 VIAL, SINGLE-DOSE in 1 BAG (0404-9811-10) / 10 mL in 1 VI... | Amidate | Henry Schein, Inc. | 2022-01-06 |
| 00409-6695-01 | 10 VIAL, SINGLE-DOSE in 1 TRAY (0409-6695-01) / 10 mL in 1... | Amidate | Hospira, Inc. | 2005-07-26 |
| 00409-6695-02 | 10 VIAL, SINGLE-DOSE in 1 TRAY (0409-6695-02) / 20 mL in 1... | Amidate | Hospira, Inc. | 2005-09-08 |
| 51662-1459-01 | 10 mL in 1 VIAL, SINGLE-USE (51662-1459-1) | AMIDATE(TM) ETOMIDATE | HF Acquisition Co LLC, DBA HealthFirst | 2020-03-31 |
| 51662-1485-01 | 10 mL in 1 VIAL, SINGLE-DOSE (51662-1485-1) | ETOMIDATE | HF Acquisition Co LLC, DBA HealthFirst | 2020-01-11 |
| 51662-1634-01 | 10 mL in 1 VIAL, SINGLE-DOSE (51662-1634-1) | ETOMIDATE injection, solution | HF Acquisition Co LLC, DBA HealthFirst | 2023-09-25 |
| 55150-0221-10 | 10 VIAL, SINGLE-DOSE in 1 CARTON (55150-221-10) / 10 mL in... | ETOMIDATE | Eugia US LLC | 2017-02-24 |
| 55150-0222-20 | 10 VIAL, SINGLE-DOSE in 1 CARTON (55150-222-20) / 20 mL in... | ETOMIDATE | Eugia US LLC | 2017-02-24 |
| 65145-0127-10 | 10 VIAL, SINGLE-DOSE in 1 CARTON (65145-127-10) / 10 mL in... | Etomidate | Caplin Steriles Limited | 2026-02-05 |
| 65145-0128-10 | 10 VIAL, SINGLE-DOSE in 1 CARTON (65145-128-10) / 20 mL in... | Etomidate | Caplin Steriles Limited | 2026-02-05 |
| 65219-0445-10 | 10 VIAL, SINGLE-DOSE in 1 CARTON (65219-445-10) / 10 mL in... | Etomidate | Fresenius Kabi USA, LLC | 2021-08-01 |
| 65219-0445-22 | 10 VIAL, SINGLE-DOSE in 1 CARTON (65219-445-22) / 10 mL in... | Etomidate | Fresenius Kabi USA, LLC | 2023-10-01 |
| 65219-0447-20 | 10 VIAL, SINGLE-DOSE in 1 CARTON (65219-447-20) / 20 mL in... | Etomidate | Fresenius Kabi USA, LLC | 2021-08-01 |
| 67457-0902-10 | 10 VIAL in 1 CARTON (67457-902-10) / 10 mL in 1 VIAL (67457... | Etomidate | Mylan Institutional LLC | 2019-03-01 |
| 67457-0903-20 | 10 VIAL in 1 CARTON (67457-903-20) / 20 mL in 1 VIAL (67457... | Etomidate | Mylan Institutional LLC | 2019-03-01 |
| 68083-0234-10 | 10 VIAL in 1 CARTON (68083-234-10) / 10 mL in 1 VIAL (68083... | Etomidate | Gland Pharma Limited | 2017-05-20 |
| 68083-0235-10 | 10 VIAL in 1 CARTON (68083-235-10) / 20 mL in 1 VIAL (68083... | Etomidate | Gland Pharma Limited | 2017-05-20 |
| 72266-0146-10 | 10 VIAL in 1 CARTON (72266-146-10) / 10 mL in 1 VIAL (72266... | Etomidate | Fosun Pharma USA Inc | 2019-09-03 |
| 72266-0147-10 | 10 VIAL in 1 CARTON (72266-147-10) / 20 mL in 1 VIAL (72266... | Etomidate | Fosun Pharma USA Inc | 2019-09-03 |
| 72485-0508-10 | 10 VIAL, SINGLE-DOSE in 1 CARTON (72485-508-10) / 10 mL in... | Etomidate | Armas Pharmaceuticals Inc. | 2024-01-22 |
| 72485-0509-10 | 10 VIAL, SINGLE-DOSE in 1 CARTON (72485-509-10) / 20 mL in... | Etomidate | Armas Pharmaceuticals Inc. | 2024-01-22 |
| 72572-0160-10 | 10 VIAL, SINGLE-DOSE in 1 CARTON (72572-160-10) / 10 mL in... | Etomidate | Civica, Inc. | 2022-03-01 |
| 72572-0161-10 | 10 VIAL, SINGLE-DOSE in 1 CARTON (72572-161-10) / 20 mL in... | Etomidate | Civica, Inc. | 2022-03-01 |
Observed labelers:
Hikma Pharmaceuticals USA Inc. (4) ·
Fresenius Kabi USA, LLC (3) ·
HF Acquisition Co LLC, DBA HealthFirst (3) ·
Armas Pharmaceuticals Inc. (2) ·
Caplin Steriles Limited (2) ·
Civica, Inc. (2)
· +6 more — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.
🗃️ Sources & Limits
Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
- A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
- Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
- Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
- Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.
Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.